News
News

The latest updates from AFAR.

Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today

Sep 6
2019

Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today View MoreBACK

On August 30, 2019  Healio’s Endocrine Today featured the insights of AFAR expert Nir Barzilai, MD, on the goals and benefits of the upcoming TAME trials, which will evaluate metformin’s clinical impact.

Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 AFAR Research Grant recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, the  Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.

Read the article, “Metformin may hold anti-aging promise to increase ‘health span’,” here.





View MoreBACK TO TOP